Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults

Sponsor
University of Toronto (Other)
Overall Status
Recruiting
CT.gov ID
NCT05810272
Collaborator
(none)
20
1
2
16
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the impact of 3-days reduced physical activity (<1500 steps/day) with/without 'exercise snacks' (15 chair stands with calf raises every 30 min) on skeletal muscle metabolic health.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Metabolic Trial
  • Behavioral: 15 sit-to-stands with calf raises
N/A

Detailed Description

Many adults gradually lose muscle size, strength, and function after the age of 50. These losses are believed to occur faster with periods of reduced activity (e.g., lower step counts or physical movement when sick or injured) and can be difficult to regain by merely returning to a previously normal activity status. Such periods of reduced activity can also impair the body's ability to use the nutrients in the food consumed (e.g., proteins and carbohydrates), which increases the risk of frailty, type 2 diabetes, and ultimately a reduced quality of life. It is important to identify strategies to prevent these losses in muscle size, strength, and function especially during periods of reduced activity.

Recently, our laboratory has found that performing repeated bodyweight chair squats (repeated sit-to-stands with a calf raise) during a single day of reduced activity improves the muscle's ability to use carbohydrates and proteins, which may be a viable strategy to offset the negative effects of step reduction on muscle health.

In this study, the investigators will assess whether completing bodyweight chair squats at regular intervals (i.e., 'exercise snacks') reduces the negative effects of step reduction on carbohydrate and protein metabolism following a meal. The investigators will determine the impact of 'exercise snacks' (15 chair stands with calf raises every 30 min) compared to seated rest on protein and carbohydrate metabolism following three days of step reduction. The investigators will also assess how these responses compare to those seen following three days of normal (i.e., habitual) activity.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Habitual Activity

Following three days of habitual activity, a metabolic trial will be completed wherein participants (10M/10F) will be assessed for their anabolic response to a protein-carbohydrate meal.

Behavioral: Metabolic Trial
Participants will undergo a metabolic trial to assess for their anabolic response to a protein-carbohydrate meal.

Experimental: Step-Reduction

Participants will undergo three days of reduced physical activity (<1,500 steps/day) prior to a metabolic trial to establish their anabolic response to a protein-carbohydrate meal.

Behavioral: Metabolic Trial
Participants will undergo a metabolic trial to assess for their anabolic response to a protein-carbohydrate meal.

Behavioral: 15 sit-to-stands with calf raises
Participants (n=10; 5F/5M) will be randomized to perform 15 sit-to-stands with calf raises every 30 minutes for the 4 hour duration between muscle biopsies
Other Names:
  • Exercise Snacks
  • Outcome Measures

    Primary Outcome Measures

    1. Myofibrillar protein synthesis rates [5 Hours]

      Myofibrillar protein synthesis rates assessed by incorporation of oral stable isotope tracer in both arms.

    Secondary Outcome Measures

    1. Whole-body protein turnover [5 Hours]

      Whole-body protein turnover assessed by oral stable isotope tracers in both arms.

    2. Amino acid oxidation and net protein balance [5 Hours]

      Amino acid oxidation and net protein balance assessed by oral tracers in both arms. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 5h measurement period.

    3. Postprandial insulin area under the curve (AUC) to mixed macronutrient breakfast [5 Hours postprandial]

      The plasma insulin concentration measured by enzyme-linked immunosorbent assay (ELISA) area under the curve (AUC) will be quantified using the trapezoidal rule.

    4. Postprandial glucose area under the curve (AUC) to mixed macronutrient breakfast [5 hours postprandial]

      The plasma glucose concentration measured by hexokinase method area under the curve (AUC) will be quantified using the trapezoidal rule.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy older (age: 60-80 y) adults

    • BMI between normal to overweight (18.5-29.9 kg/m2)

    Exclusion Criteria:
    • Regular use of nonsteroidal anti-inflammatory drugs (with the exception of daily low-dose aspirin)

    • Alcohol consumption during the study period

    • Use of anticoagulants

    • Use of a walker, cane, or assistive walking device

    • Current or recently remised cancer

    • Infectious or gastrointestinal disease

    • Inability to comply with study protocol (e.g., >1,500 steps/day during Step-Reduction Phase)

    • Regular tobacco use

    • Self-reported illicit drug use (e.g. growth hormone, testosterone, etc.)

    • Diagnosed chronic illness (e.g. type 2 diabetes, heart disease, thyroid disease)

    • Hormonal Replacement Therapy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Goldring Center for High Performance Sport Toronto Ontario Canada M5S 2C9

    Sponsors and Collaborators

    • University of Toronto

    Investigators

    • Principal Investigator: Daniel R Moore, PhD, University of Toronto
    • Study Director: Hugo JW Fung, PhD, University of Toronto

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Daniel Moore, Associate Professor in Muscle Physiology, University of Toronto
    ClinicalTrials.gov Identifier:
    NCT05810272
    Other Study ID Numbers:
    • ESPEN
    First Posted:
    Apr 12, 2023
    Last Update Posted:
    Apr 12, 2023
    Last Verified:
    Mar 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Daniel Moore, Associate Professor in Muscle Physiology, University of Toronto
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 12, 2023